An extensive study on isosorbide-5-mononitrate acid adducts for quantification in human plasma using liquid chromatography/electrospray ionization tandem mass spectrometry and its application to bioequivalence sample analysis

Rapid Communications in Mass Spectrometry

Volumn 20, Issue 19, 2006, Pages 2921-2931

  Jain, Deepak S ^a,b   Subbaiah, Gunta ^b   Sanyal, Mallika ^c   Shrivastav, Pranav S ^a   Pal, Usha ^a   Ghataliya, Shailesh ^b   Kakad, Abhijeet ^b   Bhatt, Jignesh ^b   Munjal, Vaneet ^b   Patel, Heena ^b   Shah, Sapna ^b  

^a GUJARAT UNIVERSITY   (India)

^b Torrent Pharmaceuticals Ltd   (India)

^c ST XAVIER S COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG PRODUCTS; EXTRACTION; HIGH PRESSURE LIQUID CHROMATOGRAPHY; IONIZATION; MASS SPECTROMETRY; PHASE SEPARATION; PLASMA (HUMAN);

ADDUCT FORMATION; ELECTROSPRAY IONIZATION TANDEM MASS SPECTROMETRY; HUMAN PLASMAS; ISOSORBIDE; ITS APPLICATIONS; LC-ESI-MS/MS; LC/ESI-MS/MS; LIQUID CHROMATOGRAPHY ELECTROSPRAY; LOWER LIMIT OF QUANTIFICATIONS; SAMPLE ANALYSIS;

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 33749527874     PISSN: 09514198     EISSN: 10970231     Source Type: Journal    
DOI: 10.1002/rcm.2684     Document Type: Article

References (21)

1. Needleman P, Corr PB, Johnson EM. In Goodman and Gilmans: The Pharmacological Basis of Therapeutics. (8th edn), Gilman AG, Rall TW, NIes AS, Taylor P (eds). Pergamon Press: New York, 1990.
2. Chasseaud LF. Cardiology 1987; 74: 6.
3. Major RM, Taylor T, Chasseaud LF, Darragh A, Lambe RF. Clin. Pharmacol. Ther. 1984; 35: 653.
4. Burke MJ, Preskorn SH. In Psychopharmacology: Physicians' Drug References. (59th edn), Bloom FE, Kupfer DJ. (eds). Medical Economic Company: Oradell, NJ, 2005; 3083.
5. Pommier F, Gauducheau N, Pineau V, Sioufi A, Godbillon J. J. Chromatogr. B Biomed. Sci. Appl. 1996; 678: 354.
6. Gremeau I, Sautou V, Pinon V, Rivault F, Chopineau J. J. Chromatogr. B Biomed. Sci. Appl. 1995; 665: 399.
7. Lauro-Marty C, Lartigue-Mattei C, Chabard JL, Beyssac E, Aiache JM, Nadesclaire M. J. Chromatogr. B Biomed. Sci. Appl. 1995; 663: 153.
8. Edlund PO, Johansen K. J. Chromatogr. A. 1991; 653: 21.
9. Morrison RA, Fung HL. J. Chromatogr. Biomed. Appl. 1984; 308: 153.
10. Sioufi A, Pommier F. J. Chromatogr. B Biomed. Sci. Appl. 1984; 305: 95.
11. Santoni Y, Rolland PH, Cano JP. J. Chromatogr. B Biomed. Sci. Appl. 1984; 306: 165.
12. Smith RV, Besic J. Microchem. J. 1978; 23: 185.
13. Michel G, Far L, Prost M. J. Chromatogr. Biomed. Appl. 1989; 493: 188.
14. Pennings JM, De Haas JM. J. Chromatogr. B. 1996; 675: 332.
15. Marzo A, Treffner E. J. Chromatogr. 1985; 345: 390.
16. Rosseel MT, Bogaert MG. J. Chromatogr. 1972; 64: 364.
17. Maddock J, Lewis P. A, Woodward A, Massey P. R, Kennedy S. J. Chromatogr. B Biomed. Sci. Appl. 1983; 272: 129.
18. Yu WC, Goff EU. Biopharm. Drug Dispos. 1983; 4: 311.
19. Pastera J, Vyslouzil L, Kvetina J. J. Chromatogr. B. 2004; 800: 271.
20. Silva LC, Oliveira LSOB, Mendes GD, Garica G, Pereira AS, Nucci GD. J. Chromatogr. B 2006; 832: 302.
21. FDA Guidance for Industry: Bioavailability Studies for Orally Administered Drug Products - General Considerations, US Department of Health and Human Services, Food and Drug Administration, Centre for Drug Evaluation and Research (CDER). 2000.